KIMS Hospitals Reports Strong Growth Amidst Advanced Medical Care and Multi-State Expansion
Krishna Institute of Medical Sciences Limited (KIMS) has solidified its reputation as a leading healthcare provider through sustained operational excellence and strategic expansion across multiple states. The company emphasizes a vision to provide affordable care and the best clinical outcomes, supported by a mission focused on patient-centric systems and fostering clinical outcome-driven excellence using modern medical technology.The hospital network offers comprehensive care across numerous specialities, including Neurology, Cardiology, Oncology, Nephrology, and Orthopedics. Critical care services are provided through advanced units such as ICU, CTICU, SICU, NICU, PICU, Neuro ICU, ECMO ICU, and Post Transplant ICU.
Pioneering Medical Expertise and Achievements
KIMS is recognized for pioneering advanced medical procedures and maintaining a focus on complex care. The hospital has been responsible for several "firsts" in India, including being the first in Asia to perform a Trans catheter Tricuspid Valve replacement procedure in 2018, and performing India's first COVID Double Lung transplant in 2020. The facilities boast advanced equipment such as the 4-Arm HD da Vinci Robotic Surgical System and Mako Robotic for Knee Replacement, facilitating minimally invasive and complex surgeries.In addition to its specialized departments, KIMS provides services spanning:
- Gastro Intestinal Tract: Including Liver Transplant and Bariatric Surgery.
- Genito Urinary Tract: Offering Nephrology, Urology, and Renal Transplant.
- Oncology: Covering Medical, Surgical, and Radiation Oncology, and BMT and Hematology.
- Pediatrics: Handling Neonatology and specialized pediatric care.
- Advanced Diagnostics: Providing comprehensive Pathology, Microbiology, Biochemistry, and Molecular Biology lab services.
Leadership and Corporate Structure
The company is guided by Dr. Bhaskara Rao Bollineni, Chairman & Managing Director, a Cardio-Thoracic Surgeon renowned for performing over 30,000 surgeries over 25 years. His pioneering work included founding the 'Mahavir Cardio Vascular Centre' and being instrumental in formulating the Rajiv Gandhi Aarogyasri scheme. Dr. Abhinay Bollineni serves as Executive Director & CEO.The board includes several distinguished directors, ensuring strong governance and continuous growth.
Financial and Operational Performance Highlights
The financial performance of KIMS reflects strong growth trajectories, highlighted by its increasing geographical footprint and operational volume.According to the group's financial highlights, the hospital network recorded a significant upward trend across fiscal years. Total Revenue saw a 25.0% CAGR from FY24 to FY26.
| Particulars (Rs. in Millions) | FY24 | FY25 | FY26 | YoY FY24 Vs FY25 (%) | YoY FY25 Vs FY26 (%) | CAGR FY24 to FY26 (%) |
|---|---|---|---|---|---|---|
| Operating Revenue | 24,982 | 30,351 | 39,046 | 21.5% | 28.6% | 25.0% |
| Total Revenue | 25,143 | 30,670 | 39,308 | 22.0% | 28.2% | 25.0% |
| EBITDA | 6,533 | 8,148 | 8,282 | 24.7% | 1.6% | 12.6% |
| PAT | 3,359 | 4,148 | 2,420 | 23.5% | (41.7%) | (15.1%) |
Operational metrics also showed robust growth, with the total bed capacity expanding significantly:
| Year | Andhra Pradesh | Telangana | Maharashtra | Kerala | Karnataka | Tamil Nadu |
|---|---|---|---|---|---|---|
| 2000 | Nellore - 250 | |||||
| 2004 | Secunderabad - 1000 | |||||
| 2011 | Srikakulam - 300 | |||||
| 2014 | Kondapur - 220 | |||||
| 2017 | Ongole - 350 | |||||
| 2018 | Vizag - 434 | |||||
| 2022 | Begumpet - 369 | Nagpur - 334 | ||||
| 2024 | Vizag II - 335 | Asian Transcare - 60 | Nashik - 325 | Kannur - 189 | ||
| 2025 | Guntur Shikara (O&M) - 200 | Sangli (O&M) - 350 | Kollam - 320 | Mahadevapura - 450 | ||
| 2026 | Kompally (O&M) - 200 | |||||
| Planned | Kondapur II - 800 | Palakkad - 210 | Chennai - 300 |
The group operates a massive network of over 8600+ beds, demonstrating ambitious growth plans for future years.
Growth Strategy and Awards
KIMS continues to drive growth through several strategic levers, including regional market leadership, developing high-quality care through affordable models, and establishing doctor partnerships via equity participation. This strategy underpins the plan to add over 1300+ beds through greenfield developments and acquisitions.The organization's commitment to quality is evidenced by numerous accolades, including:
- American Accreditation Commission International (AACI) Accreditation.
- Pharmacie De Qualite (PDQ) Certification, achieving a PLATINUM grade.
- Recognition as 'Best Hospital to Work For' at the AHPI Global Conclave Award (2019).
- Being ranked as the No. 1 Hospital by the Times of India, Hyderabad.
- Achieving NABH Digital Standards Accreditation for its Kondapur facility.
KIMS Stock Price Movement
On Friday, Krishna Institute of Medical Sciences Limited shares slipped by 0.94% to close at ₹761.65. The stock experienced active trading, settling on a volume of 592,313 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: